Andrey V Peresypkin

Title: Innovations of Andrey V Peresypkin: A Pioneer in Pharmaceutical Research

Introduction

Andrey V Peresypkin, an accomplished inventor based in Cranford, NJ, has made significant contributions to the field of pharmaceuticals through his innovative research and patented inventions. With a total of three patents to his name, he has focused on developing novel compounds and processes that hold promise for various medical applications.

Latest Patents

Among his latest patents, Andrey has developed a process for producing a crystalline form of a Melanocortin-4 receptor (MC4R) agonist. This invention, titled "Crystalline forms of MC4R agonist and process for synthesis," includes methods for synthesizing N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, along with novel crystalline salts, hydrates, solvates, and polymorphic forms thereof.

Additionally, he has developed techniques related to "Radiolabeled cannabinoid-1 receptor modulators." This patent covers particular radiolabeled cannabinoid-1 (CB1) receptor modulators and their use in diagnostic imaging of CB1 receptors in mammals, including humans. His invention also discloses intermediates useful for the synthesis of these modulators, as well as formulations of the radiolabeled compounds.

Career Highlights

Andrey's professional journey includes significant roles at renowned pharmaceutical companies, such as Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience at these organizations reflects his expertise in drug development and innovation in therapeutic solutions.

Collaborations

Throughout his career, Andrey has collaborated with notable colleagues, including Alex Minhua Chen and Robert Wenslow. Their combined efforts have contributed to the advancement of research and development projects, leading to substantial innovations in the pharmaceutical landscape.

Conclusion

Andrey V Peresypkin stands out as a leading inventor with a strong track record in the pharmaceutical sector. His innovative patents exemplify his commitment to advancing medical research and developing effective therapeutic compounds. Through his work and collaborations, he continues to make valuable contributions to science and medicine.